VERAVera Therapeutics, Inc.
$30.62+7.6% 1Y
$30.62
$24.1052 weeks$55.67
The business
How VERA's business earns
- Share count, year on year
- +13%
Share count, year on year · more shares than a year ago
Details›
- Free cash flow, trailing twelve months
- −$376M
- Net income, trailing twelve months
- −$415M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Biotechnology
The closest names by size in the same industry